drugset / Trial / NCT07715175

A Pharmacokinetic Study of D-2570 in Trial Participants With Renal Impairment Versus Normal Renal Function

NCT07715175

Phase 1 Not yet recruiting 40 enrolled InventisBio Co., Ltd
Non-randomizedParallel-groupOpen-labelOther

Summary

This study is divided two parts into: Part A and Part B. Part A will recruit 24 research participants, and Part B will recruit 16 research participants.

Timeline

Start
2026-08-09
Primary completion
2026-11-21
Completion
2026-11-21

Drugs

EvaluationDrugModalityDoseRoute
Subject D-2570 Unknown Oral